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a b s t r a c t
The text book view of cell surface receptors depicts them at the top of a vertical chain of command that
starts with ligand binding and proceeds in a lineal fashion towards the cell nucleus. Although pedagog-
ically useful, this view is incomplete and recent findings suggest that the extracellular domain of cell
surface receptors can be a transmitter as much as a receiver in intercellular communication. GFRa1 is
a GPI-anchored receptor for GDNF (glial cell line-derived neurotrophic factor), a neuronal growth factor
with widespread functions in the developing and adult nervous system. GFRa1 partners with transmem-
brane proteins, such as the receptor tyrosine kinase RET or the cell adhesion molecule NCAM, for intra-
cellular transmission of the GDNF signal. In addition to this canonical role, GFRa1 can also engage in
horizontal interactions and thereby modify the function of other cell surface components. GFRa1 can also
function as a ligand-induced adhesion cell molecule, mediating homophilic cell–cell interactions in
response to GDNF. Finally, GFRa1 can also be released from the cell surface and act at a distance as a sol-
uble factor together with its ligand. This plethora of unconventional mechanisms is likely to be a feature
common to several other receptors and considerably expands our view of cell surface receptor function.
! 2010 Elsevier Inc. All rights reserved.
1. Vertical signaling by GDNF receptor complexes
Neurotrophic factors are key regulators of neuronal survival,
differentiation, migration synapse formation and function in both
the developing and adult nervous systems. GDNF (glial cell line-
derived neurotrophic factor) was originally isolated from the
supernatant of a glial cell line based on its effects on the survival
of midbrain dopaminergic neurons, those that degenerate in Par-
kinson’s disease [1]. It was later found that GDNF has effects on
many other types of neurons in both the peripheral and central
nervous systems [2]. The first GDNF receptor to be identified was
RET, a receptor tyrosine kinase that had been found mutated in
endocrine human cancers and cases of Hirschsprung disease [3].
Although required for GDNF function, RET was found to be unable
to bind the factor on its own, leading to the discovery of the GFRa1
(GDNF family receptor alpha 1) subunit through expression-clon-
ing efforts [4]. GFRa1 is anchored to the plasma membrane via a
GPI link and hence lacks transmembrane and intracellular do-
mains. Three other factors with sequence homology to GDNF were
subsequently identified, termed Neurturin, Artemin and Persephin,
respectively [2]. Although RET mediates the signaling of all mem-
bers of the GDNF family, three additional GPI-linked co-receptors
related to GFRa1, termed GFRa2, 3 and 4, were found to specifi-
cally bind each of the newly identified family members [2]. In
the mammalian brain, expression of GFRa1 and 2 is more promi-
nent, while GFRa3 and 4 are predominantly found in the periphe-
ral nervous system and other organs, respectively. The GDNF/
GFRa1/RET complex activates many of the signaling pathways that
have been characterized in other receptor tyrosine kinases, such as
the Ras/MAPK, PI3K/Akt and PLCc pathways [5] (Fig. 1A), and sev-
eral recent studies have begun to dissect the importance of each of
these pathways for the neurotrophic actions of this receptor com-
plex [2].
Since GFRa1 lacks an intracellular domain, the fact that this
receptor appeared expressed in many brain areas in the absence
of RET was taken as an indication that additional signaling recep-
tors might exist [6]. Several intracellular events elicited by GDNF
were subsequently described in cells expressing GFRa1 but lacking
RET [7]. Together with chemical cross-linking studies, these in-
sights led to the discovery of the neural cell adhesion molecule
NCAM as an alternative signaling receptor for GDNF and related
molecules [8]. NCAM had been known for its ability to mediate cell
adhesion as well as a handful of downstream signaling events trig-
gered by homophilic NCAM interactions [9]. Unlike RET, however,
NCAMwas found to be able to bind GDNF directly, but high-affinity
binding and downstream signaling required the presence of GFRa1
[8], and molecular modeling and site-directed mutagenesis studies
revealed that GDNF specifically interacts with the third Ig domain
of NCAM [10,11]. An NCAM mutant has been generated that is
unable to bind GDNF but which still retains the ability to mediate
cell adhesion [10], indicating that the two functions can be genet-
ically separated. Downstream signaling by NCAM in response to
GDNF has been shown to involve events similar to those elicited
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by homophilic interactions, including activation of Fyn kinase [8]
(Fig. 1A). Through the NCAM/GFRa1 complex, GDNF has been
shown to regulate cell migration, neuronal morphology and syn-
apse formation [8,11–13].
2. Horizontal interactions regulate NCAM-mediated cell
adhesion
In addition to its classical role as a GDNF receptor, GFRa1 also
engages in horizontal interactions that affect the function of other
cell surface components. As reviewed above, GFRa1 has been
shown to form a complex with NCAM, and this interaction has
been thought to be important for GDNF high-affinity binding and
downstream signaling through the GFRa1/NCAM complex [8].
One intriguing effect of the binding of GFRa1 to NCAM is the
downregulation of NCAM’s ability to mediate cell adhesion [8]
(Fig. 1B). Even low relative levels of GFRa1 can cause NCAM to
be significantly less competent at triggering homophilic cell–cell
interactions, an effect that it is independent of the presence of
GDNF. Binding of GFRa1 to NCAM presumably masks important
determinants for homophilic NCAM interactions. Because GFRa1
and NCAM are co-expressed in several populations of migratory
neuronal precursors in the developing and adult brain, such as
those in the rostral migratory stream (RMS), this finding may have
important implications for the control of cell migration through
regulation of the cell adhesion activity of NCAM [14].
The interaction between GFRa1 and NCAM is direct, and more
recent work has shown it to be mediated by the N-terminal do-
main of GFRa1 and the fourth Ig domain of NCAM [15]. The N-ter-
minal domain of GFRa1 does not participate in GDNF binding, but
it is both required and sufficient to inhibit NCAM-mediated cell
adhesion [15], a finding that identifies the first known function
for this region of the GFRa1 molecule. Unfortunately, current three
dimensional models of GFRa molecules based on the crystal struc-
tures of the GFRa1/GDNF and GFRa3/Artemin complexes lack any
atomic information on the N-terminal domain, so additional stud-
ies will be required to shed light on this important region of the
GFRa family of molecules. Intriguingly, the N-terminal domain of
GFRa1 is dispensable for the ability of GFRa1 to potentiate GDNF
binding to NCAM [15]. Together these data indicate that direct
receptor–receptor interactions are not required for high affinity
GDNF binding to NCAM but play an important role in the regula-
tion of NCAM-mediated cell adhesion by GFRa1. They illustrate
how even relatively small cell surface receptors can have diverse
functions at the cell membrane, i.e. through both vertical and hor-
izontal interactions, via different regions of their extracellular
domains.
3. Ligand-induced cell adhesion
An intriguing function of GFRa1, not directly related to its abil-
ity to mediate intracellular signaling, was accidentally discovered
Fig. 1. Multitasking in GFRa1 receptor function. (A) Vertical signaling together with RET or NCAM. (B) Horizontal interactions downregulate NCAM-mediated cell adhesion.
(C) Ligand-induced cell adhesion. (D) Non-cell-autonomous action at a distance.
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during the course of investigations on the trophic activities of
GDNF in cultures of hippocampal neurons. GDNF was shown to
induce the formation of synapses in those cultures, an effect that
required the expression of GFRa1 on the neurons [13]. Biochemical
and immunocytochemical studies helped to establish the presence
of the receptor at both the pre- and post-synaptic sides of hippo-
campal synapses. The realization that many other synaptic cell sur-
face molecules that contribute to synapse formation, such as
Neuroligins/Neurexins, DSCAM and Ephrins/Ephs, also have the
ability to mediate cell adhesion, led to investigations of the adhe-
sive properties of GFRa1. Although the receptor was by itself not
able to mediate cell adhesion in standard cell aggregation assays,
it was found that addition of GDNF induced a robust and long-last-
ing response, promoting the formation of large cell clusters similar
to those typically observed upon overexpression of bona fide cell
adhesion molecules, such as NCAM [13]. Because cell adhesion
was only observed after addition of the GDNF ligand, the term
ligand-induced cell adhesion (LICA) was coined to differentiate this
novel process from other more traditional mechanisms of cell–cell
interaction in which cell adhesion is a direct, default consequence
of the mere expression of cell adhesion molecules at the cell sur-
face (Fig. 1C). LICA uniquely combines the features of soluble and
cell-associated molecules to mediate cell adhesion in a way that
becomes amenable to exquisite regulation by either the participat-
ing cells themselves—in a cell-autonomous fashion—or standby
cellular components in a non-cell-autonomous way through the
production and release of the GDNF ligand. There are no other
examples known of ligand-induced cell adhesion molecules
(LICAMs) but it is possible that many other cell surface receptors
function in this way.
Importantly, LICA was not simply a consequence of GDNF being
a dimer and GFRa1 being able to bind GDNF in dimeric form. Other
receptors known to interact with dimeric ligands as receptor
homodimers, such as the NGF receptors TrkA and p75NTR, are not
able to function as LICAMs ([13] and unpublished results). This
would argue against a simple trans-homodimerization mechanism
with the ligand functioning as a ‘‘glue” between the interacting
cells, although it remains possible that unique features of the
GDNF/GFRa1 complex may allow this to happen. Another possibil-
ity is that GDNF induces some kind of conformational change in
GFRa1 that exposes receptor determinants able to mediate homo-
philic cell–cell interactions. However, recent crystallographic stud-
ies of the GDNF/GFRa1 complex do not support the existence of
such a conformational change [16]. Moreover, and although the
GFRa1 N-terminal domain was not present in the crystal structure
of the complex, its deletion does not affect the LICAM activity of
GFRa1 [13]. If neither GDNF nor GFRa1 are directly responsible
for cell–cell contact, it remains possible that additional compo-
nents, such as for example extracellular matrix elements, may play
a role. Regardless of the mechanism, the LICA phenomenon has
emerged as a novel way in which cell–cell interactions can be
formed and regulated, and has important implications for a myriad
of morphogenetic events including cell migration, axon growth and
synapse formation.
4. Non-cell-autonomous effects: soluble GFRa1 acts
at a distance
As with most GPI-anchored receptors, GFRa1 is efficiently shed
from the cell surface in a constitutive manner by the action of
membrane-associated phospholipases. Soluble GFRa1 binds GDNF
with high affinity, is very stable, and can be readily recovered from
the supernatant of GFRa1-expressing cell lines and tissues, such as
lesioned peripheral nerves [17]. Several studies have shown that
released GFRa1 can act at a distance to potentiate downstream sig-
naling, neuronal survival and neurite outgrowth in response to
GDNF [17,18]. The discovery that peripheral targets of innervation
of sensory and sympathetic axons express high levels of GFRa1
prompted the study of potential axon-guidance activities of GFRa1
released by target cells. It was found that soluble GFRa1 could cap-
ture GDNF, present it to axonal RET receptors and thereby induce
axon growth in a directional fashion [18] (Fig. 1D). Target-derived
GFRa1 could thus function as a long-range directional cue for
growing axons [19]. These effects were found to be mediated by
activation of the Cdk5 kinase, which had previously been linked
to neuritic growth and axon guidance. Interestingly, the roles of
Cdk5 in GFRa1-mediated growth and guidance could be dissoci-
ated. Specifically, it could be shown that higher levels of Cdk5
activity are required for directional responses to exogenous GFRa1
which were sensitive to low levels of Cdk5 inhibitors [18].
A feature shared by GPI-anchored proteins is that they can be
found in either membrane bound or soluble forms. Secretion of
biological, active GFRa1 by known targets of RET-expressing neu-
rons may form diffusible gradients that could promote long-range
effects on developing axons. On the other hand, GPI-anchored
GFRa1 expressed on stand-by cells can also capture and present
GDNF in trans to RET receptors on adjacent cells [17]. Thus, GFRa1
has the capacity to elicit both long-range and localized guidance
effects by creating positional information for RET-expressing axons
even in the presence of a uniform concentration of GDNF. GFRa1
can thereby rearrange GDNF into a spatial pattern that may be dif-
ferent from the initial pattern of GDNF gene expression. These re-
sults have unraveled a novel role for cell surface receptors through
an ability to act at a distance, non-cell-autonomously, on other
cells. A mutant mouse generated to test some of these ideas failed
to show an effect following deletion of GFRa1 from selected groups
of target tissues [20]. Further investigations of the in vivo relevance
of non-cell-autonomous activities of GFRa1 will require novel ani-
mal models carrying altered versions of the GFRa proteins.
5. Concluding remarks
Studies on the structure and function of the GFRa1 protein have
revealed a wider functional landscape than what was initially
anticipated. Cell surface receptors can not only function in a tradi-
tional—vertical—fashion by binding an extracellular ligand and
mediating signals across the plasma membrane, but also engage
in a number of alternative interactions, both in the plane of the
membrane and beyond (Fig. 1). The examples described here illus-
trate the many ways in which intercellular communication can
take place and extend the classical concept of cell surface receptor
to one encompassing functions that were either unknown to exist
or thought to require dedicated groups of molecules.
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